5-FU
Showing 1 - 25 of >10,000
ive Exposure to 5-FU in Locally Advanced, Resectable Gastric or
Recruiting
- TDM of 5-FU
- Pharmacokinetic Observational Study
- Extra blood samples for determining exposure to 5-FU
-
Eindhoven, Noord-Brabant, NetherlandsCatharina hospital
Dec 28, 2022
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Metastatic Colorectal Cancer Trial in Toronto (Hydroxychloroquine, Irinotecan, Leucovorin)
Not yet recruiting
- Metastatic Colorectal Cancer
- Hydroxychloroquine
- +4 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 24, 2023
Colorectal Cancer Trial (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab, HR070803 simulator plus oxaliplatin, 5-FU/LV,
Not yet recruiting
- Colorectal Cancer
- HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab
- HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab
- (no location specified)
Jul 13, 2023
Squamous Cell Carcinoma of Head and Neck Trial in Hangzhou (Toripalimab)
Recruiting
- Squamous Cell Carcinoma of Head and Neck
-
Hangzhou, Zhejiang, ChinaDepartment of Medical Onocology, First Affiliated Hospital of Zh
Oct 7, 2023
Gastric Cancer, Gastroesophageal-junction Cancer, Advanced Cancer Trial (TST001, CapOx or mFOLFOX6 and NIVO or (Substudy)
Not yet recruiting
- Gastric Cancer
- +2 more
- TST001, CapOx or mFOLFOX6 and NIVO or (Substudy) TST001, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- Placebo CapOx or mFOLFOX6 and NIVO or (Substudy) Placebo, Oxaliplatin and capecitabine or 5-fluorouracil (5-FU)
- (no location specified)
Oct 16, 2023
Metastatic Pancreatic Ductal Adenocarcinoma Trial in Belgium (Nanoliposomal irinotecan, 5 FU, Leucovorin)
Recruiting
- Metastatic Pancreatic Ductal Adenocarcinoma
- Nanoliposomal irinotecan
- +3 more
-
Brugge, West-Vlaanderen, Belgium
- +11 more
Jul 25, 2022
Basal Cell Carcinoma, BCC Trial in Aleppo (5-Fluorouracil, SURGERY)
Recruiting
- Basal Cell Carcinoma
- BCC
- 5-Fluorouracil
- SURGERY
-
Aleppo, Syrian Arab RepublicIbrahim Arnaout
Nov 28, 2023
Carcinoma, Squamous Cell Trial in Pittsburgh (5-fluorouracil, Imiquimod 5% cream)
Recruiting
- Carcinoma, Squamous Cell
- 5-fluorouracil
- Imiquimod 5% cream
-
Pittsburgh, PennsylvaniaSt. Margaret Hospital Dermatology
Oct 6, 2022
Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)
Not yet recruiting
- Actinic Keratosis
- Biopsy
- +2 more
-
Tucson, Arizona
- +3 more
Jan 25, 2023
Rectal Cancer Trial in Mannheim (mFOLFOX (neoadjuvant), XELOX (neoadjuvant), mFOLFOX (adjuvant))
Recruiting
- Rectal Cancer
- mFOLFOX (neoadjuvant)
- +6 more
-
Mannheim, GermanyUnversity Hospital Mannheim
Aug 12, 2022
Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)
Not yet recruiting
- Metastatic Pancreatic Cancer
- nanoliposomal irinotecan
- spleen irradiation
- (no location specified)
May 8, 2022
CIN 2/3, HIV Trial in Lilongwe (Intravaginal 5-Fluorouracil (5-FU))
Not yet recruiting
- CIN 2/3
- HIV Infections
- Intravaginal 5-Fluorouracil (5-FU)
-
Lilongwe, MalawiUNC Project, Kamuzu Central Hospital
Jan 17, 2023
Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,
Recruiting
- Colorectal Cancer
- +4 more
- Fosifloxuridine Nafalbenamide
- +4 more
-
Wichita, Kansas
- +5 more
Jan 9, 2023
Actinic Keratoses Trial in Worldwide (5-fluorouracil 4% (Tolak), Dexeryl)
Completed
- Actinic Keratoses
- 5-fluorouracil 4% (Tolak)
- Dexeryl
-
Arras, France
- +26 more
Sep 15, 2022
Colorectal Cancer, Esophagus Cancer, Appendix Cancer Trial (FOX dose-escalation algorithm)
Not yet recruiting
- Colorectal Cancer
- +4 more
- FOX dose-escalation algorithm
- (no location specified)
Mar 24, 2023
Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab + Envafolimab + mFOLFOXIRI
- Cetuximab + mFOLFOX6/FOLFIRI
- (no location specified)
Jul 24, 2023
Temporal Bone Squamous Cell Carcinoma Trial in Guangzhou (Paprizumab combined with cisplatin and 5-FU)
Recruiting
- Temporal Bone Squamous Cell Carcinoma
- Paprizumab combined with cisplatin and 5-FU
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 5, 2022
POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)
Terminated
- POLE Exonuclease Mutant Colon Cancer
- +2 more
-
Sutton, Surrey, United KingdomRoyal Marsden NHS Foundation Trust
Oct 5, 2022
Stage II Colon Cancer, Stage III Colon Cancer Trial (5-Fluorouracil continuous infusion FOLFOXIRI schedule, 5-Fluorouracil bolus
Not yet recruiting
- Stage II Colon Cancer
- Stage III Colon Cancer
- 5-Fluorouracil continuous infusion FOLFOXIRI schedule
- +8 more
- (no location specified)
Aug 3, 2022
5-FU Exposure Optimization in CRC Patients
Completed
- Metastatic Colorectal Cancer
- +2 more
-
La Jolla, California
- +4 more
Feb 15, 2022
Oral Leukoplakia Trial in San Francisco (5-fluorouracil)
Not yet recruiting
- Oral Leukoplakia
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 15, 2022
Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)
Terminated
- Colorectal Cancer
- Regorafenib
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 10, 2022
Metastatic Colorectal Cancer Trial in Madrid (Aflibercept, Irinotecan, folinic acid (dl racemic))
Active, not recruiting
- Metastatic Colorectal Cancer
- Aflibercept
- +4 more
-
Madrid, SpainSpanish Cooperative Group for Digestive Tumour Therapy (TTD)
Oct 10, 2022